Machine learning models can accurately predict which cancer patients are most likely to initiate an IV therapy within 90 days of their diagnosis, and what informs that decision, according to a presentation at the 2023 annual meeting of the American Society of Clinical Oncology (abstract e13539).
“We can use machine learning to build predictive models to tell people what could happen in the future,” said Ping Ye, PhD, a senior data scientist with The US Oncology Network, a